An India-based, leading specialty pharmaceuticals company consulted Freyr for Regulatory support in the compilation, evaluation, and submission of an Amendment to the USFDA. The project presented challenges such as reviewing various documents received from the customer, identifying the gaps, and compiling the relevant data required for the Amendment. Freyr’s team helped the customer achieve their business goals by working within stringent timelines and ensuring the updated documents were filed with the Agency without any discrepancies.
Learn how Freyr helped file the Amendment submission to the USFDA by collaborating with all the stakeholders and ensuring compliance. Download the proven case.